Yuyu Pharma Overview
- Year Founded
-
1941
- Status
-
Public
- Employees
-
254
- Stock Symbol
-
000220
- Investments
-
5
- Share Price
-
$2.84
- (As of Friday Closing)
Yuyu Pharma General Information
Description
Yuyu Pharma Inc. manufactures and markets medicines. The product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.
Contact Information
Website
www.yuyu.co.krCorporate Office
- Yuyu Building, 197 Dongho-ro
- Jung-gu
- Seoul, 04598
- South Korea
Corporate Office
- Yuyu Building, 197 Dongho-ro
- Jung-gu
- Seoul, 04598
- South Korea
Yuyu Pharma Stock Performance
As of 13-Nov-2026, Yuyu Pharma’s stock price is $2.84. Its current market cap is $44.8M with 15.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.84 | $2.84 | $2.30 - $3.46 | $44.8M | 15.7M | 108K | $0.53 |
Yuyu Pharma Financials Summary
As of 30-Jun-2026, Yuyu Pharma has a trailing 12-month revenue of $99M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 45,754 | 60,451 | 52,630 | 92,500 |
| Revenue | 99,480 | 98,996 | 97,584 | 104,944 |
| EBITDA | 13,946 | 11,840 | 13,091 | 1,394 |
| Net Income | 8,616 | 5,730 | 6,391 | (5,492) |
| Total Assets | 134,726 | 143,904 | 140,999 | 153,811 |
| Total Debt | 18,183 | 19,391 | 22,841 | 30,579 |
Yuyu Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Yuyu Pharma Patents
Yuyu Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025149851-A2 | Methods for treating inflammatory diseases | Inactive | 12-Jan-2024 | ||
| WO-2025149851-A3 | Methods for treating inflammatory diseases | Inactive | 12-Jan-2024 | ||
| CA-3170606-A1 | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | Pending | 05-Mar-2020 | ||
| EP-4114430-A2 | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | Inactive | 05-Mar-2020 | ||
| EP-4114430-A4 | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | Inactive | 05-Mar-2020 | A61K38/08 |
Yuyu Pharma Signals
Yuyu Pharma Investments (5)
Yuyu Pharma’s most recent deal was a Early Stage VC with Vetmab Bio for . The deal was made on 29-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vetmab Bio | 29-Sep-2026 | Early Stage VC | Other Commercial Services | ||
| James & Ella | 04-Feb-2026 | Later Stage VC | Other Consumer Non-Durables | ||
| Dalan | 02-Dec-2025 | Later Stage VC | Other Pharmaceuticals and Biotechnology | ||
| Dog PPL | 09-Apr-2025 | Later Stage VC | Leisure Facilities | ||
| Yuyu Teijin Medicare | 01-Jan-2006 | Joint Venture | Therapeutic Devices |
Yuyu Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Yuyu Pharma FAQs
-
When was Yuyu Pharma founded?
Yuyu Pharma was founded in 1941.
-
Where is Yuyu Pharma headquartered?
Yuyu Pharma is headquartered in Seoul, South Korea.
-
What is the size of Yuyu Pharma?
Yuyu Pharma has 254 total employees.
-
What industry is Yuyu Pharma in?
Yuyu Pharma’s primary industry is Pharmaceuticals.
-
Is Yuyu Pharma a private or public company?
Yuyu Pharma is a Public company.
-
What is Yuyu Pharma’s stock symbol?
The ticker symbol for Yuyu Pharma is 000220.
-
What is the current stock price of Yuyu Pharma?
As of 13-Nov-2026 the stock price of Yuyu Pharma is $2.84.
-
What is the current market cap of Yuyu Pharma?
The current market capitalization of Yuyu Pharma is $44.8M.
-
What is Yuyu Pharma’s current revenue?
The trailing twelve month revenue for Yuyu Pharma is $99M.
-
What is Yuyu Pharma’s annual earnings per share (EPS)?
Yuyu Pharma’s EPS for 12 months was $0.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process